JELGO

This brand name is authorized in Turkey

Active ingredients

The drug JELGO contains a combination of these active pharmaceutical ingredients (APIs):

1 Diethylamine salicylate
UNII 5V7PT38BJU - DIETHYLAMINE SALICYLATE

Diethylamine salicylate is a topical analgesic, with the anti-inflammatory properties of salicylates. It is believed to exert cortisone-like action, stimulating the pituitary-adrenal axis, exerting an analgesic and anti-inflammatory effect.

Read about Diethylamine salicylate
2 Escin
UNII RUU8G67GQM - ESCIN
Read about Escin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M02AC Preparations with salicylic acid derivatives M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8699772340012

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈